- Home
- PMCB vs RAYA Comparison
PMCB vs RAYA Comparison
Compare PMCB & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- RAYA
- Stock Information
- Founded
- PMCB 1996
- RAYA 2019
- Country
- PMCB United States
- RAYA China
- Employees
- PMCB N/A
- RAYA N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- RAYA Metal Fabrications
- Sector
- PMCB Health Care
- RAYA Consumer Discretionary
- Exchange
- PMCB Nasdaq
- RAYA Nasdaq
- Market Cap
- PMCB 6.6M
- RAYA 6.1M
- IPO Year
- PMCB N/A
- RAYA 2022
- Fundamental
- Price
- PMCB $0.94
- RAYA $0.04
- Analyst Decision
- PMCB
- RAYA
- Analyst Count
- PMCB 0
- RAYA 0
- Target Price
- PMCB N/A
- RAYA N/A
- AVG Volume (30 Days)
- PMCB 118.7K
- RAYA 60.5M
- Earning Date
- PMCB 09-12-2025
- RAYA 01-01-0001
- Dividend Yield
- PMCB N/A
- RAYA N/A
- EPS Growth
- PMCB N/A
- RAYA N/A
- EPS
- PMCB 3.19
- RAYA N/A
- Revenue
- PMCB N/A
- RAYA $30,300,360.00
- Revenue This Year
- PMCB N/A
- RAYA $20.95
- Revenue Next Year
- PMCB N/A
- RAYA N/A
- P/E Ratio
- PMCB $0.30
- RAYA N/A
- Revenue Growth
- PMCB N/A
- RAYA 49.10
- 52 Week Low
- PMCB $0.80
- RAYA $0.04
- 52 Week High
- PMCB $2.42
- RAYA $3.35
- Technical
- Relative Strength Index (RSI)
- PMCB 47.20
- RAYA 27.46
- Support Level
- PMCB $0.92
- RAYA $0.05
- Resistance Level
- PMCB $1.00
- RAYA $0.07
- Average True Range (ATR)
- PMCB 0.09
- RAYA 0.01
- MACD
- PMCB 0.00
- RAYA 0.06
- Stochastic Oscillator
- PMCB 28.69
- RAYA 18.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.